Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

July 31, 2019 by Alan Khadavi

Chronic Cough; Management and Diagnosis

Explore how camlipixant, a selective P2X3 antagonist, reduces cough frequency and improves quality of life in patients with refractory chronic cough.

People with chronic cough can experience significant quality of life impairment. Cough is a fundamental protective reflex that can become disordered and lead to a persistent symptom complex that limits quality of life.  The assessment should consider whether it is a manifestation of a significant underlying disease such as pneumonia, cardiac failure or an exacerbation […]

Filed Under: Blog

July 18, 2019 by Alan Khadavi

Cat vaccine to prevent allergies in owners

A cat vaccine is being developed to decrease the amount of allergy that cats produce.  Cats are found in about 25% of households in the United States and allergy to cats is found in approximately 10% of the population.  The major cat allergen found in saliva and dander is called Fel d 1, and this […]

Filed Under: Blog, Headlines, Immunotherapy

July 18, 2019 by Alan Khadavi

Auvi-Q 0.1 mg for infants and toddlers

auvi-q 0.1 mg

Auvi-Q 0.1 mg is being used for children weighing 16.5 to 33 pounds.  In a previous post we discussed this when it first came out. Auvi-Q 0.1 mg dose approved for infants and children The Auvi-Q 0.1 mg has a smaller needle length and there is less risk of hitting a bone, which could result […]

Filed Under: Anaphylaxis, Blog

June 25, 2019 by Alan Khadavi

Early-life undernutrition and asthma

Early-life undernutrition is closely correlated with higher risk of asthma in offspring.  The early life is critically important for later adult health.  Early-life undernutrition leads to growth restriction and it can be responsible for impaired lung development and respiratory function from the fetal period to adulthood. Asthma involves chronic allergic airway inflammation characterized by airway […]

Filed Under: Asthma, Blog

June 13, 2019 by Alan Khadavi

Dupixent for Hives

chronic spontaneous urticaria

Dupixent for hives is novel treatment option for patients with difficult to treatment chronic spontaneous urticaria.  Chronic hives is a common condition marked by episodes of elevated, itching, red wheals persisting for more than 6 weeks without a specific known cause.  It is estimated that chronic hives affects about 1% of the population. The mechanism […]

Filed Under: biologics, Blog, hives, Urticaria

May 30, 2019 by Alan Khadavi

Benralizumab (Fasenra) in asthma

Itepekimab and Brodalumab

Benralizumab (Fasenra) is an interleukin (IL)-5 receptor monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils in the circulation. Benaralizumab is approved for use in Canada, Europe, Japan and the U.S. In the United States, it is indicated for the add-on treatment of patients with asthma aged 12 and up with an […]

Filed Under: Asthma, biologics, Blog

May 22, 2019 by Alan Khadavi

Allergies and Medicare

gefapixant

Allergies affect so many people that they’re in the top 10 list of the most chronic illnesses in the county. According to the American College of Allergy, Asthma, and Immunology (ACAAI), a staggering 50 million Americans suffer from some form of allergies. Allergies may take the form of allergic rhinitis (hay fever), eczema, asthma, and […]

Filed Under: Blog

May 21, 2019 by Alan Khadavi

Will my child outgrow asthma?

outgrow asthma

Predicting whether a child will outgrow asthma has important implications for patients, parents and doctors. Past studies have estimated between 15% to 64% of patients with childhood asthma go into remission by early adulthood.  In those studies asthma remission rates have been noted to vary widely by population, and remission has been associated with less […]

Filed Under: Asthma, Blog, Pediatric

May 8, 2019 by Alan Khadavi

Costs of Asthma Biologic Medications

costs of asthma biologics

The costs of asthma biologic medications can be quite expensive.  Currently on the market there are 5 available. Xolair (omalizumab) Nucala (mepolizumab) Cinqair (reslizumab) Fasenra (benralizumab) Dupixent (Dupilumab) We have discussed each of them extensively in previous post. Xolair (Omalizumab) for Chronic Urticaria (this post discusses Xolair’s approval for chronic urticaria (hives) it was approved for […]

Filed Under: biologics, Blog

May 2, 2019 by Alan Khadavi

Mast Cell Activation Syndrome (MCAS): Fact & Fiction

mcas

Mast cell activation syndrome (MCAS) is a rare condition defined by a severe systemic reaction to mast cell derived mediators.  Mast cells are effector cells of the immune system.  These cells produce a variety of proinflammatory mediators and participate in a number of different pathological conditions.  In patients the risk of developing severe anaphylactic (hypersensitivity) events […]

Filed Under: Blog, Headlines, Urticaria

  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page